NCT05764954View on ClinicalTrials.gov

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Adenocarcinoma of Lung
Interventions
DEVICE

NovoTTF-200T System

The device is applied continuously for an average duration of 18 hours per day for 3 weeks (+/- 1 week).

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Consent Only), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Consent Only), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Consent Only), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Consent Only), Montvale

All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER